Clinical Trials in Philadelphia

Showing 5361-5380 of 15,860 trials

Assessment of Macrophage Activation syndromE in STill's Disease

NCT06405152

Assessment of Macrophage activation syndrome in STill's disease: retrospective chart analysis of patient History, Symptom resolution and Treatment characteristics

Macrophage Activation SyndromeStill's Disease, Adult-OnsetStills Disease, Juvenile-Onset

Swedish Orphan Biovitrum75 participantsStarted Sep 2023

Los Angeles, California, United States • Atlanta, Georgia, United States • Cincinnati, Ohio, United States +8 more locations

WITHDRAWNPhase 1/2< 1 mile

Safety and Efficacy of IMC-C103C as Monotherapy and in Combination With Atezolizumab

NCT03973333

IMC-C103C is an immune mobilizing monoclonal T cell receptor against cancer (ImmTAC ®) designed for the treatment of cancers positive for the tumor-associated antigen MAGE-A4. This is a first-in-human trial designed to evaluate the safety and efficacy of IMC-C103C in adult patients who have the appropriate HLA-A2 tissue marker and whose cancer is positive for MAGE-A4.

Select Advanced Solid Tumors

Immunocore LtdStarted May 2019

Los Angeles, California, United States • Sacramento, California, United States • Aurora, Colorado, United States +16 more locations

Assessment of Macrophage Activation syndromE in STill's Disease

Safety and Efficacy of IMC-C103C as Monotherapy and in Combination With Atezolizumab

Find Trials by Condition in Philadelphia

Sleep in Pediatric HSCT

Hypotension Prediction Index Study (HPI Study)

Caspofungin Acetate, Fluconazole, or Voriconazole in Preventing Fungal Infections in Patients Following Donor Stem Cell Transplant

Closed Incision Negative Pressure Therapy Versus Standard of Care Surgical Dressing in Revision Total Knee Arthroplasty

REVEAL 2 Trial (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL)

A Phase IIb, Multicenter, Open-Label, Prospective Study of Bremelanotide in Diabetic Kidney Disease

PK and Dose Escalation and Expansion Study of DST-2970

Milademetan in Advanced/Metastatic Solid Tumors

A Study of ALKS 4230 (Nemvaleukin Alfa) With Pembrolizumab in Head and Neck Cancer

Anti-inflammatory Drugs and Serum Prostate-Specific Antigen Test

SL-401 as Consolidation Therapy in Patients With Adverse Risk Acute Myeloid Leukemia in First Complete Remission

Bone in CKD Alkali Response (BICARb Pilot Trial)

Vogelxo(R) ABPM Study in Hypogandal Men

Valganciclovir Therapy in Infants and Children With Congenital CMV Infection and Hearing Loss

Study of Monovalent and Bivalent Recombinant Protein Vaccines Against COVID-19 in Adults 18 Years of Age and Older

Study of IMC-I109V in Non-cirrhotic HBeAg-negative Chronic HBV Infection

Study Investigating the Safety and Efficacy of Blinatumomab in Combination With Pembrolizumab in Adults With Relapsed or Refractory Diffuse Large B Cell Lymphoma (DLBCL)

MK-2060 and Clopidogrel Co-administration Safety and Tolerability Study in Participants With End-Stage Renal Disease (ESRD) (MK-2060-008)